Sort
172,184 grants matching “inflammation”
Clinical Evaluation of PET Radiotracers
$3,163,585Robert Innis · National Institute Of Mental Health · ZIA · FY2014 · MH
Translational studies in allergic reactions and inflammation
$3,155,225Jonathan Lyons · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study
$3,155,165E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2024 · AG
New Mexico IDeA Networks of Biomedical Research Excellence
$3,153,764Jeffrey B Arterburn · New Mexico State University Las Cruces · P20 · FY2008 · RR
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
$3,148,529John M. Sedivy · Brown University · P01 · FY2025 · AG
UCSF-Bay Area Center for AIDS Research
$3,146,338Monica Gandhi · University Of California, San Francisco · P30 · FY2025 · AI
Complications of Hemolysis and Transfusion Therapy
$3,142,533Karina Yazdanbakhsh · New York Blood Center · P01 · FY2020 · HL
Eukaryotic Transcriptional Regulation
$3,141,632Paul A Wade · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Laboratory of Molecular Imaging and Nanomedicine
$3,139,811Xiaoyuan Chen · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2011 · EB
Human neuropeptide transmitter systems are dysregulated in Alzheimer's disease pathogenesis
$3,138,871Vivian Y. H. Hook · University Of California, San Diego · RF1 · FY2025 · AG
University of Washington Sexually Transmitted Infections Cooperative Research Cen
$3,135,008Anna Wald · University Of Washington · U19 · FY2018 · AI
Emory-CDC CTU
$3,134,849Jeffrey Lennox · Emory University · UM1 · FY2021 · AI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
$3,130,730Joren C Madsen · Massachusetts General Hospital · U01 · FY2023 · AI
Resolving the mechanisms of IFIH1 risk variant in systemic lupus erythematosus
$3,130,679Jacquelyn Gorman · Oklahoma Medical Research Foundation · R01 · FY2025 · AI
Discovery and Trial Ready Cohort for Limbic Predominant Age Related TDP-43 Encephalopathy (TRC LATE)
$3,128,129Seyed Ahmad Sajjadi · University Of California-Irvine · R01 · FY2025 · AG
Duke/UNC Alzheimer's Disease Research Center
$3,128,004Heather E. Whitson · Duke University · P30 · FY2021 · AG
Optimizing anti-microbial immunity by targeting Sts-1
$3,125,627Nicholas A Carpino · State University New York Stony Brook · R01 · FY2025 · AI
Preterm Epo Neuroprotection Trial (PENUT Trial) CCC
$3,121,909Sandra E Juul · University Of Washington · U01 · FY2014 · NS
Complications of Hemolysis and Transfusion Therapy
$3,121,462Karina Yazdanbakhsh · New York Blood Center · P01 · FY2021 · HL
Environmental Influences on Child Health Outcomes in Puerto Rico (ECHO-PRO)
$3,118,380Akram N Alshawabkeh · Northeastern University · UH3 · FY2020 · OD
Environmental Influences on Child Health Outcomes in Puerto Rico (ECHO-PRO)
$3,118,380Akram N Alshawabkeh · Northeastern University · UH3 · FY2021 · OD
Environmental Influences on Child Health Outcomes in Puerto Rico (ECHO-PRO)
$3,118,380Akram N Alshawabkeh · Northeastern University · UH3 · FY2022 · OD
Genetic Regulation of Human Beta Cell Destruction
$3,116,568Clayton E Mathews · University Of Florida · UC4 · FY2014 · DK
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i
$3,112,198Joel Barry Baseman · University Of Texas Hlth Science Center · U19 · FY2011 · AI
Case Clinical Trials Unit
$3,112,121Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2020 · AI